Cerebras IPO Filed After Expanded OpenAI Deal

Cerebras IPO filing on April 17, 2026 follows an expanded OpenAI commitment and could boost IPO demand while supporting a higher valuation for the IPO.

April 17, 2026·2 min read
View all news articles
Flat vector of a single massive chip expanding compute array that symbolizes the Cerebras IPO and expanded OpenAI deal

KEY TAKEAWAYS

  • Filed S-1 on April 17, 2026 reviving its IPO after an October 2025 withdrawal.
  • Targets a $35.0 billion valuation and plans to raise more than $3.0 billion in the IPO.
  • OpenAI expanded its commitment to over $20.0 billion and fronted about $1.0 billion that alters customer mix.

HIGH POTENTIAL TRADES SENT DIRECTLY TO YOUR INBOX

Add your email to receive our free daily newsletter. No spam, unsubscribe anytime.

Or subscribe with

Cerebras Systems filed S-1 paperwork for a U.S. initial public offering on April 17, 2026, aiming to leverage an expanded OpenAI commitment that supports multi-year compute sales and changes the company’s customer mix.

IPO Filing and Valuation

The filing revives Cerebras’s public-offering effort, which was withdrawn in October 2025 after regulatory scrutiny over customer concentration. The AI chipmaker targets a $35 billion valuation and plans to raise more than $3 billion in the IPO.

That valuation implies a 43.0% premium to the $8.1 billion mark from a September 2025 Series G round and a 52.0% premium to a $23 billion valuation from a February 2026 Series H round. Prior private financing included a $1.1 billion Series G in September 2025; total private funding is cited at roughly $715–720 million across seven rounds.

OpenAI Deal and Regulatory Impact

OpenAI revised its commitment to spend more than $20 billion on Cerebras servers and compute over three years, doubling the initial January 2026 agreement of about $10 billion. The deal includes warrants that could give OpenAI up to a 10.0% equity stake if cumulative spending reaches $30 billion.

Part of the arrangement was recorded as a working-capital deposit, with OpenAI fronting roughly $1 billion toward data-center construction, which Cerebras booked as a balance-sheet asset. OpenAI and Amazon are confirmed as major customers, and the company has partnered with Oracle to deliver its systems through cloud services.

Previously, G42 accounted for 87.0% of Cerebras’s revenue in the first half of 2024, triggering a national-security review that contributed to the earlier IPO withdrawal. CEO Andrew Feldman said in May 2025 the company obtained clearance to sell shares to G42.

Executives have cited the expanded OpenAI partnership as the reason for restarting the IPO and setting the higher target valuation, saying the agreement underwrites multi-year demand and reduces the customer-concentration risks that complicated the prior offering.

HIGH POTENTIAL TRADES SENT DIRECTLY TO YOUR INBOX

Add your email to receive our free daily newsletter. No spam, unsubscribe anytime.

Or subscribe with

Read other top news stories

Meta Business Agent Expands Into Enterprise AI

Meta Business Agent Expands Into Enterprise AI

Meta Business Agent brings AI to WhatsApp, Messenger and Instagram, launches free with paid plans planned and creates a revenue path investors will track.

GitLab Guidance Rises as AI Momentum Offsets Cuts

GitLab Guidance Rises as AI Momentum Offsets Cuts

GitLab guidance rose as the company raised outlook and approved restructuring to refocus investment on AI and platform growth, shifting trader positioning.

Macy's Q1 Earnings Lift Outlook

Macy's Q1 Earnings Lift Outlook

Macy's Q1 earnings prompted a raised FY26 outlook on June 3, 2026 after its first year-over-year sales gain in nearly four years and luxury strength.

Palantir Stock Slips After Earnings Beat, Insider Sales

Palantir Stock Slips After Earnings Beat, Insider Sales

Palantir stock shows post-earnings volatility after a Q1 2026 beat and Form 4 insider sales, with heavy options flow and divergent analyst targets.

Medtronic Earnings Beat, Signal Decade-High Growth

Medtronic Earnings Beat, Signal Decade-High Growth

Medtronic earnings showed strongest annual revenue growth in 10 years led by cardiac ablation; mixed margins and softer FY27 guidance tighten trader focus

ADP Jobs May 2026 Signal Hiring Rebound

ADP Jobs May 2026 Signal Hiring Rebound

ADP Jobs May 2026 showed private hiring beat forecasts with broad gains led by small firms and 4.4% pay growth, a near-term labor signal for traders.